lergotrile mesylate , an ergot alkaloid derivative and putative dopamine agonist , was effective in the majority of patients with parkinson 's disease who were showing signs of disease progression despite treatment with levodopa combined with a peripheral decarboxylase inhibitor ( carbidopa ) .
C0030567
parkinson 's disease
C0006982
carbidopa